Creation Technologies Launches FDA UDI Compliance Program


Reading time ( words)

Creation Technologies, award-winning EMS provider with electronics design, rapid prototyping and manufacturing locations around the globe, has announced its milestone achievement of the USA Food and Drug Administration (FDA) Unique Device Identification (UDI) Compliance for Class I, Class II and Class III medical device labeling across its global operations.

As an established contract design and manufacturing partner for leading medical device OEMs, Creation’s manufacturing facilities are ISO 13485-certified and FDA-registered. With the recent FDA-mandated UDI compliance date of September 24, 2016 for Class II medical devices, Creation has achieved internal compliance with the regulation. Moreover, the company has announced implementation of a proprietary new tool and automated process within its Vision manufacturing execution system and customer portal that enables its customers to obtain real-time data and device tracking information in support of their UDI compliance.

"Creation Technologies is committed to exceeding all patient safety requirements on behalf of our innovative OEM medical customers. Achieving FDA UDI System compliance for all medical device classes in advance of the 2020 deadline demonstrates this commitment. Creation believes integrating critical UDI traceability information into our Vision system adds exceptional value," said Tim Holzschuh, Director of Regulatory & Quality – Creation Design Services. "The medical device industry anticipates that the return on investment for the UDI System will include less reporting of adverse events, faster regulatory submission turn-around times, and more efficient post-market vigilance."

Additional information about the FDA’s Unique Device Identification requirements can be found in UDI Basics and other resources on the FDA’s website.

About Creation Technologies

Medical device and biotechnology companies working with Creation Technologies have scalable options for risk mitigation and rapid growth through the company’s turnkey solutions that include connected device design and development, rapid prototyping, manufacturing, fulfillment and logistics for complex systems, and VAVE and sustaining engineering.

With FDA-registered and ISO 13485-certified manufacturing facilities and design centers across Canada, USA, Mexico and China, Creation Technologies provides real-time visibility and traceability to its medical customers in markets from cardiovascular to urology imaging to radiation oncology.

Share

Print


Suggested Items

LPKF on Stencils and Depaneling

02/11/2020 | I-Connect007 Editorial Team
Stephan Schmidt and Mirela Orlowski of LPKF Laser & Electronics North America discuss laser technology in cutting stencils and depaneling circuit boards as a factor in shrinking component sizes and why few people in the industry realize how much of an impact the stencil can have on the manufacturing line.

Is Captive Making a Comeback?

12/20/2019 | Andy Shaughnessy, Design007 Magazine
Andy Shaughnessy recently spoke with Altium’s Steve Chalgren, senior VP of business strategy and planning. Steve shared his thoughts about why improved manufacturing and automated EMS equipment, such as robotics, might lead smaller OEMs to become captive shops like the old days. Is captive making a comeback?

Keith Bryant on Growth in the European Market

11/06/2019 | Pete Starkey, I-Connect007
Pete Starkey interviews Keith Bryant, chairman of the European division of the Surface Mount Technology Association (SMTA), about his view on the outlook of the industry, including growth in the European electronics manufacturing industry as well as the need for young engineers.



Copyright © 2020 I-Connect007. All rights reserved.